The Clorox Company (NYSE:CLX) Shares Bought by Federated Hermes Inc.

Federated Hermes Inc. increased its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 483.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 27,696 shares of the company's stock after purchasing an additional 22,952 shares during the quarter. Federated Hermes Inc.'s holdings in Clorox were worth $3,949,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of CLX. Fortitude Family Office LLC bought a new position in Clorox in the fourth quarter valued at about $29,000. Tyler Stone Wealth Management lifted its holdings in Clorox by 64.5% in the third quarter. Tyler Stone Wealth Management now owns 255 shares of the company's stock valued at $33,000 after acquiring an additional 100 shares during the period. Hartford Financial Management Inc. lifted its holdings in Clorox by 57.1% in the fourth quarter. Hartford Financial Management Inc. now owns 256 shares of the company's stock valued at $37,000 after acquiring an additional 93 shares during the period. Valley National Advisers Inc. lifted its holdings in Clorox by 458.3% in the fourth quarter. Valley National Advisers Inc. now owns 268 shares of the company's stock valued at $38,000 after acquiring an additional 220 shares during the period. Finally, BKM Wealth Management LLC purchased a new stake in Clorox in the fourth quarter worth about $41,000. 78.53% of the stock is owned by institutional investors.

Clorox Trading Down 0.7 %

Shares of NYSE:CLX traded down $1.02 during trading on Friday, hitting $146.48. The company had a trading volume of 1,191,766 shares, compared to its average volume of 1,000,632. The stock has a market cap of $18.18 billion, a price-to-earnings ratio of 232.51, a price-to-earnings-growth ratio of 2.33 and a beta of 0.43. The Clorox Company has a one year low of $114.68 and a one year high of $178.21. The company has a fifty day simple moving average of $149.39 and a two-hundred day simple moving average of $142.60. The company has a debt-to-equity ratio of 11.37, a current ratio of 0.89 and a quick ratio of 0.57.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Thursday, February 1st. The company reported $2.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $1.08. The business had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.80 billion. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The company's revenue for the quarter was up 16.0% on a year-over-year basis. During the same period last year, the company earned $0.98 EPS. As a group, equities analysts forecast that The Clorox Company will post 5.52 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be paid a $1.20 dividend. This represents a $4.80 annualized dividend and a dividend yield of 3.28%. The ex-dividend date is Tuesday, April 23rd. Clorox's payout ratio is 761.92%.

Analysts Set New Price Targets

A number of analysts have commented on the company. UBS Group upped their price target on Clorox from $145.00 to $170.00 and gave the stock a "neutral" rating in a research report on Friday, February 2nd. Barclays reduced their price target on Clorox from $148.00 to $136.00 and set an "underweight" rating for the company in a research report on Wednesday, April 10th. DA Davidson reiterated a "neutral" rating and set a $162.00 target price on shares of Clorox in a research report on Wednesday, April 17th. The Goldman Sachs Group initiated coverage on Clorox in a research report on Friday, March 1st. They set a "sell" rating and a $140.00 target price for the company. Finally, Citigroup cut their target price on Clorox from $165.00 to $155.00 and set a "neutral" rating for the company in a research report on Tuesday, April 16th. Four analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company's stock. According to data from MarketBeat.com, Clorox has an average rating of "Hold" and an average target price of $148.63.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.